Financial News

Financial Report: Merck

Pharmaceutical sales were up 2% to $11.3 billion in the quarter, driven primarily by growth in oncology and certain hospital acute care products.

By: Contract Pharma

Contract Pharma Staff

Merck 3Q Revenues: $12.6 billion (+1%) 3Q Earnings: $2.9 billion (+55%) YTD Revenues: $35.5 billion (+1%) YTD Earnings: $9.2 billion (+22%) Comments: Pharmaceutical sales were up 2% to $11.3 billion in the quarter, driven primarily by growth in oncology and certain hospital acute care products, partially offset by the negative impact of the COVID-19 pandemic and the ongoing impacts of the loss of market exclusivity for several products. KEYTRUDA sales were up 21% to $3.7 bill...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters